About Emergent What We Do COVID-19 UPDATES Careers Investors Newsroom Main navigation Toggle Menu Search Snapshot Snapshot Trading Statistics Balance Sheet Income Statement Cash Flow Ratios Revenue & Earnings Revenue (FY) $1,555.40 EBIT (Mil) (FY) $480.10 EBIT (Mil) (MRQ) $-34.70 EBIT (Mil) (TTM) $336.80 EBITDA (Mil) (FY) $594.60 EBITDA (Mil) (MRQ) $-2.00 EBITDA (Mil) (TTM) $460.30 Net Income Excluding Extraordinary Items (Mil) (FY) $305.10 Net Income Including Extraordinary Items (Mil) (FY) $305.10 Diluted EPS Excluding Extraordinary Items (FY) $5.67 Diluted EPS Including Extraordinary Items (FY) $5.67 Ratios Price to Revenue (TTM) $1.41 Price to Revenue (MRQ) $1.76 Price to Revenue (FY) $1.49 Price To Cash Flow (TTM) $6.63 Price to Cash Flow (MRQ) -- Price to Cash Flow (FY) $5.54 Price to Book (MRQ) $1.52 Price to Book (FY) $1.58 Total Debt to Equity (MRQ) (%) 55.75% Total Debt to Equity (FY) (%) 60.46% Current Ratio (MRQ) $3.04 Current Ratio (FY) $3.11 Growth 5-Year Annual Dividend Growth Rate (%) --% 5-Year Annual Revenue Growth Rate (%) 26.02% FY = Fiscal Year. MRQ = Most Recent Quarter. mil = Millions. TTM = Trailing Twelve Months. Copyright Refinitiv Investor Relations Investors Governance News Financials SEC Filings Financial Reports Quarterly Results Fundamentals Events Stock Resources Investor Toolkit Print Page RSS Feeds Email Alerts Online Investor Kit Investor FAQs Information Request QUICK LINKS Corporate Fact Sheet Shareholders Careers Contact Us Personal Information Request Form Menu Column One Company Overview Our Vision History Awards Innovation Menu Column Two Contract Manufacturing Products Pipeline Platforms & Technologies Manufacturing Expertise Menu Column Three Press Releases Featured Stories Videos Leadership Governance © 2021 Emergent BioSolutions Inc. All rights reserved. PRIVACY PRINCIPLES